Welcome
Chairs: M. Kontos, V. Kouloulias, M. Koukourakis
09.00-09.20 Surgery S. Lanitis
09.20-09.40 Radiation therapy E. Mosa
09.40-10.00 Comments I. Natsiopoulos
10.00-10.30 Discussion E. Faliakou, G. Kyrgias, K. Tepetes,
C. Tsionou, G. Xepapadakis
Chairs: A. Nonni, N. Timotheadou
10.45-11.10 The pathologist perspective E. Kourea
11.10-11.35 The medical oncologist perspective Ι. Athanasiadis
11.35-12.00 Discussion C. Andreadis, M. Ignatiadis,
M. Ioannou, Ch. Kourousis
Chairs: V. Venizelos, C. Papadimitriou
Updates in axillary surgery considering the results of MonarchE and RxPONDER E. Mamounas
Chairs: V. Georgoulias, C. Kalofonos
12.30-12.50 ER+ disease Y. Markou
12-50-13.10 ER+ disease II, HER2-positive and triple-negative E. Kontopodis
13.10-13.30 Comments Evandro De Azambuja
13.30-14.00 Discussion C. Christodoulou, G. Lamprodimou, V. Papadopoulos
Lunch Break
Chairs: A. Koutras, K. Papazisis
15.00-15.20 ER+ disease I E. Lalla
15.20-15.40 ER-positive II and HER2-positive S. Karageorgopoulou
15.40-16.00 Tackling endocrine resistance in
advanced breast cancer V. Kaklamanis
16.00-16.30 Discussion N. Androulakis, A. Kotsakis,
A. Alexopoulos, E. Razis
Chairs: C. Panopoulos, A. Psyrri
16.30-16.50 Survivorship A. Zavos
16.50-17.10 Discussion A. Ardavanis, A. Daponte,
I. Drositis, D. Papageorgiou
Chairs: S. Agelaki, D. Tryfonopoulos
17.10-17.30 Basic research N. Prekete
17.30-17.50 Risk stratification F. Fostira
17.50-18.10 Discussion V. Barbounis, C. Emmanouilidis,
T. Foukakis, D. Mauri
Adjourn